Skip to content
The Policy VaultThe Policy Vault

Thalomid (thalidomide) — Medica

Castleman disease

Initial criteria

  • Patient has relapsed/refractory or progressive disease OR (Patient has multi-centric disease AND is negative for HIV and human herpesvirus-8)

Approval duration

1 year